GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » AfterNext HealthTech Acquisition Corp (NYSE:AFTR) » Definitions » Cash And Cash Equivalents

AfterNext HealthTech Acquisition (AfterNext HealthTech Acquisition) Cash And Cash Equivalents : $0.02 Mil (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is AfterNext HealthTech Acquisition Cash And Cash Equivalents?

AfterNext HealthTech Acquisition's quarterly cash and cash equivalents declined from Dec. 2022 ($0.68 Mil) to Mar. 2023 ($0.34 Mil) but then stayed the same from Mar. 2023 ($0.34 Mil) to Jun. 2023 ($0.02 Mil).

AfterNext HealthTech Acquisition's annual cash and cash equivalents increased from . 20 ($0.00 Mil) to Dec. 2021 ($1.74 Mil) but then declined from Dec. 2021 ($1.74 Mil) to Dec. 2022 ($0.68 Mil).


AfterNext HealthTech Acquisition Cash And Cash Equivalents Historical Data

The historical data trend for AfterNext HealthTech Acquisition's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AfterNext HealthTech Acquisition Cash And Cash Equivalents Chart

AfterNext HealthTech Acquisition Annual Data
Trend Dec21 Dec22
Cash And Cash Equivalents
1.74 0.68

AfterNext HealthTech Acquisition Quarterly Data
Apr21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only 1.17 0.94 0.68 0.34 0.02

AfterNext HealthTech Acquisition Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


AfterNext HealthTech Acquisition  (NYSE:AFTR) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


AfterNext HealthTech Acquisition Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of AfterNext HealthTech Acquisition's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


AfterNext HealthTech Acquisition (AfterNext HealthTech Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
301 Commerce Street, Suite 3300, City Fort Worth, TX, USA, 76102
Website
AfterNext HealthTech Acquisition Corp is a blank check company.
Executives
Jon Winkelried director, 10 percent owner C/O GOLDMAN, SACHS & CO., 85 BROAD STREET, NEW YORK NY 10004
Tpg Gp A, Llc director, 10 percent owner 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
R Halsey Wise director, officer: Chief Executive Officer 135 PONTE VEDRA BLVD, PONTE VEDRA BEACH FL 32082
Julie L. Gerberding director 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
David Bonderman director, 10 percent owner 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
James G Coulter director, 10 percent owner 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Tpg Group Holdings (sbs) Advisors, Inc. director, 10 percent owner C/O TPG GLOBAL, LLC, 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Jeffrey K. Rhodes director C/O TPG GLOBAL, LLC, 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Christopher H. Hunter director 500 W MAIN STREET, LOUISVILLE KY 40202
Bharat Sundaram director 100 NORTH POINT CENTER EAST, SUITE 200, ALPHARETTA GA 30022
Martin Davidson officer: Chief Financial Officer C/O TPG PACE ENERGY HOLDINGS CORP., 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Nehal Raj director C/O TPG GLOBAL, LLC, 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Anthony Jr Colaluca director, officer: President MULTIPLAN CORPORATION, 115 FIFTH AVENUE, NEW YORK NY 10003
William Joseph Miller director 4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251
Agneta G. Breitenstein director C/OAFTERNEXT HEALTHTECH ACQUISITION CORP, 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102

AfterNext HealthTech Acquisition (AfterNext HealthTech Acquisition) Headlines